Under construction – not a live service
Sign in
Taking peopleNo phase

Construction and Empirical Research of a Risk Prediction Model for Preventing Lower Extremity Arteriosclerosis Obliterans in Diabetic Patients Based on the HAPA Model

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Second Affiliated Hospital of Nanchang University
Trial code
NCT07881588
Record updated
19 October 2026
Original description
In this study, Logistic regression analysis was used to construct a risk prediction model for ASO in diabetic patients. Guided by the HAPA model, a nursing intervention plan for preventing ASO in diabetic patients was constructed and verified, with the aim of reducing the occurrence of ASO in diabetic patients and providing a reference for improving the quality of life of diabetic patients in clinical practiceRead full original descriptionShow less

In this study, Logistic regression analysis was used to construct a risk prediction model for ASO in diabetic patients. Guided by the HAPA model, a nursing intervention plan for preventing ASO in diabetic patients was constructed and verified, with the aim of reducing the occurrence of ASO in diabetic patients and providing a reference for improving the quality of life of diabetic patients in clinical practice

Inclusion: Meet the clinical diagnostic criteria for type 2 diabetes; Age ≥18 years old; The patient is conscious, has no language communication barriers, and has certain reading and writing abilities; The patient or caregiver can use smart devices; Informed consent and voluntary participation.

Exclusion: Combined with other serious physical diseases, such as malignant tumors, etc; Have a history of mental illness; Patients who already have lower extremity arterial disease; Those with severe audio-visual or cognitive impairments.

ClinicalTrials.gov NCT07881588